Evidence map›Paper›PMID 26874842›Full record

ArticleCurrent treatment options in neurology2016

Treatment of Edema Associated With Intracerebral Hemorrhage.

Audrey Leasure, W Taylor Kimberly, Lauren H Sansing, Kristopher T Kahle, Golo Kronenberg, Hagen Kunte, J Marc Simard, Kevin N Sheth

Abstract read
PubMed Publisher
In one paragraph

Article in Current treatment options in neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Medical versus neurosurgical treatment in ICH patients: a single center experience.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Observational
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. [Current treatment concepts in intracerebral hemorrhage].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2017
    Review
  13. Soluble CD163 in intracerebral hemorrhage: biomarker for perihematomal edema.Annals of clinical and translational neurology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Audrey LeasureDepartment of Neurology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT, 06510, USA. audrey.leasure@yale.edu.
W Taylor KimberlyDepartment of Neurology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. wtkimberly@mgh.harvard.edu.
Lauren H SansingDepartment of Neurology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT, 06510, USA. lauren.sansing@yale.edu.
Kristopher T KahleYale Program on Neurogenetics, Department of Neurosurgery and Pediatrics, 333 Cedar Street, New Haven, CT, 06510, USA. kristopher.kahle@yale.edu.
Golo KronenbergDepartment of Neurology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany. golo.kronenberg@charite.de.
Hagen KunteDepartment of Neurology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany. hagen.kunte@charite.de.
J Marc SimardDepartment of Neurosurgery, University of Maryland School of Medicine, 22 South Greene Street, Baltimore, MD, 21201-1559, USA. msimard@smail.umaryland.edu.
Kevin N ShethDepartment of Neurology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT, 06510, USA. kevin.sheth@yale.edu.
Yale University · USCharité - Universitätsmedizin Berlin · DEMassachusetts General Hospital · USUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

opinion statementCerebral edema (i.e., "brain swelling") is a common complication following intracerebral hemorrhage (ICH) and is associated with worse clinical outcomes. Perihematomal edema (PHE) accumulates during the first 72 h after hemorrhage, and during this period, patients are at risk of clinical deterioration due to the resulting tissue shifts and brain herniation. First-line medical therapies for patients symptomatic of PHE include osmotic agents, such as mannitol in low- or high-dose bolus form, or boluses of hypertonic saline (HTS) at varied concentrations with or without subsequent continuous infusion. Decompressive craniectomy may be required for symptomatic edema refractory to osmotherapy. Other strategies that reduce PHE such as hypothermia and minimally invasive surgery have shown promise in pilot studies and are currently being evaluated in larger clinical trials. Ongoing basic, translational, and clinical research seek to better elucidate the pathophysiology of PHE to identify novel strategies to prevent edema formation as a next major advance in the treatment of ICH.

Indexed as

Hyperosmolar therapyICPIntracerebral hemorrhagePerihematomal edemaSecondary brain injury

Identifiers

PMID26874842
OpenAlexW2315060851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.